Le Lézard
Classified in: Health, Covid-19 virus
Subject: NPT

Final Call To Apply For The 2022 Biocodex Microbiota Foundation $50,000 U.S. Research Grant


October 1, 2022, Deadline Approaching for Application Submission

BEDMINSTER, N.J.,  September 26, 2022 /PRNewswire-PRWeb/ -- With the submission deadline approaching, the Biocodex Microbiota Foundation is calling for final grant applications from early-career investigators studying gut microbiota in human health and disease, including Covid-19, sleep disorders, the brain-gut axis and other evolving gut health research. The $50,000 research grant, now in its 6th year, is juried by a panel of medical and scientific experts in the field and can be applied to a new or existing study. The application can be downloaded here and deadline for entry is October 1, 2022, 5PM EST.

This is the sixth consecutive year the Biocodex Microbiota Foundation has awarded the $50,000 US grant, which aims to advance research and understanding of human microbiota.

"The study of the gut microbiota and its role in human health and disease is crucial for understanding the connections of the gut with the rest of the body, along with the discovery of novel health management solutions for these conditions," says Julien Dureisseix, General Manager of Biocodex, Inc. "The Biocodex Microbiota Foundation's mission is to help advance research and deepen the understanding of human microbiota. We at Biocodex are excited to continue the tradition of supporting up and coming researchers in this field."

Julia Brown, MD, PhD., who is currently a Postdoctoral Associate in Pediatrics at Weill Cornell Medical College, received the 2021 grant to help further her research into the neonatal gut microbiome and its role in lung immune development and antiviral immunity.

"The Biocodex Microbiota Foundation grant has helped further the efforts to understand how the microbiome contributes to the heightened risks of severe RSV in preterm infants by dysregulating the immune response," Dr. Brown explains. "We are currently working to identify specific bacteria or metabolites that are responsible for these effects, which could potentially offer therapeutic strategies to improve immune function in preterm infants by manipulating the microbiome."

Other Biocodex Microbiota Foundation $50,000 grant recipients include:

The Biocodex Microbiota Foundation's annual call for grant applications is part of a multi-year research initiative to recognize the interaction between microbiota and different pathologies. The 2022 applications will be reviewed, and recipient selected, by the US Biocodex Microbiota Foundation's scientific board, comprised of Dr. Ruth Ann Luna from Texas Children's Hospital and Baylor College of Medicine, Dr. Emeran Mayer from University of California Los Angeles (UCLA), and Dr. Erica Sonnenburg from Stanford University.

The ideal applicant is a US-based researcher with five or less years of research experience within the microbiota field seeking to establish themselves as an independent researcher. All finalized applications must be sent to [email protected] by the October 1, 2022, 5 p.m. EST deadline. Late or incomplete applications, or those that don't meet the criteria of the grant program or research topic will not be considered.

To learn more information about Biocodex Microbiota Foundation and the 2022 US grant program, click here.

About the Biocodex Microbiota Foundation:

The Biocodex Microbiota Foundation's mission is to support research into microbiota and its interaction with various pathologies. Research is reinforced through grants given to projects that examine the implication of microbiota in human health. The Biocodex Microbiota Foundation supports both foundational and applied research, and projects are selected annually by a committee of independent scientists.
The foundation's primary activity remains the awarding of annual grants to innovative scientific research projects that explore the structure and impact of microbiota. In addition, the foundation also runs and helps establish programs to improve our understanding of microbiota and disseminates this knowledge as widely as possible, including scientific communities and via public projects aimed to help improve human health.

The Biocodex Microbiota Foundation is a non-profit, general interest organization. For more information about the foundation's international research grants, visit here.

Media Contact

Rabina Begum, RLA Collective, a Ruder Finn Company, 646-541-3057, [email protected]

 

SOURCE Biocodex Microbiota Foundation


These press releases may also interest you

at 06:50
Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved BEQVEZtm (fidanacogene elaparvovec-dzkt) for the treatment of adults with moderate to severe hemophilia B who currently use factor IX (FIX) prophylaxis...

at 06:08
The Annual General Meeting of Bioretec Ltd was held on 26 April 2024 in Tampere, Finland. The Annual General Meeting approved the financial statements for the financial year 1 January?31 December 2023 and resolved to discharge the members of the...

at 06:00
IDEAYA Biosciences, Inc. , a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that, on April 25, 2024, the Compensation Committee of IDEAYA's Board of Directors granted...

at 06:00
-- Diluted EPS of $2.16; Adjusted Diluted EPS of $2.26 ---- Increases 2024 Full Year Guidance -- 2024 adjusted diluted EPS of $2.26, up over 7% from $2.11 in the first quarter of 2023.Increases 2024 full year adjusted diluted EPS guidance by $0.10 to...

at 06:00
Avantor, Inc. , a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today reported financial results for its first...

at 05:12
Swedish Orphan Biovitrum AB (publ) (Sobi®) has established a medium term note programme with a framework amount of SEK 10 billion or the equivalent thereof in EUR (the "MTN Programme"). For this purpose, Sobi has prepared a base prospectus, which...



News published on and distributed by: